2 hours Verastem (NASDAQ:VSTM) Now Covered by Analysts at Guggenheim MarketBeat
Guggenheim assumed coverage on Verastem in a report on Monday. They set a “buy” rating and a $13.00 target price for the company.
Guggenheim assumed coverage on Verastem in a report on Monday. They set a “buy” rating and a $13.00 target price for the company.